Read the latest from Sharon Faust, PharmD, MBA, Chief Pharmacy Officer at Navitus, as she discusses how reforming PBM incentives could reshape drug pricing to deliver billions in savings: #DrugTrendReport #HealthCareCosts #PBMTransparency #Biosimilars To view or add a comment, sign in Natco Pharma Surges After Delhi HC Approves Sale of Risdiplam in India In a significant development for Indias healthcare sector, Natco Pharmas stock rose 6% after receiving court approval to sell Risdiplam, a rare disease treatment previously restricted in India
For the broader pipeline context around these compounds, see our investigational peptide drugs for diabetes and obesity reviews 2019-2026 guide
Rybelsus is an oral semaglutide formulation
Treatment failure with disease-modifying antirheumatic drugs in rheumatoid arthritis patients
ROS can enhance the production of these cytokines by activating transcription factors like NF-B and AP-1, creating a feed-forward loop that amplifies inflammation and tissue damage
Checa, J
